Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Toho Holdings Co., Ltd. ( (JP:8129) ) just unveiled an announcement.
Toho Holdings’ outside directors have rejected a request from shareholder 3D Investment Partners Pte. Ltd. to establish a new third-party committee to investigate past violations of the Antimonopoly Act, arguing that the company’s governance and compliance systems have been significantly overhauled since the incidents, which occurred six to ten years ago. Citing extensive reforms already under way—including the work of a Governance Enhancement Special Committee, a 12-point action plan to improve oversight, and a shift toward forward-looking priorities such as capital efficiency, governance effectiveness and personnel reform—the outside directors concluded that revisiting past events would divert resources from initiatives aimed at enhancing corporate value and protecting the common interests of shareholders.
The most recent analyst rating on (JP:8129) stock is a Hold with a Yen5269.00 price target. To see the full list of analyst forecasts on Toho Holdings Co., Ltd. stock, see the JP:8129 Stock Forecast page.
More about Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. is a Japan-based pharmaceutical wholesaler operating in the drug distribution and healthcare-related services industry. Listed on the Prime Market of the Tokyo Stock Exchange, the company focuses on supplying pharmaceuticals and medical products, and in recent years has emphasized strengthening its governance and compliance framework following past antitrust issues.
Average Trading Volume: 165,027
Technical Sentiment Signal: Buy
Current Market Cap: Yen305.3B
See more insights into 8129 stock on TipRanks’ Stock Analysis page.